420 related articles for article (PubMed ID: 25628424)
1. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
4. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Serup AK; Albers PH; Hansen DL; Worm D; Naver L; Kristiansen VB; Wojtaszewski JF; Kiens B; Holst JJ; Richter EA; Madsbad S
Diabetes; 2014 May; 63(5):1725-37. PubMed ID: 24241533
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
6. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
7. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
[TBL] [Abstract][Full Text] [Related]
8. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
9. Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.
Lund MT; Hansen M; Skaaby S; Dalby S; Støckel M; Floyd AK; Bech K; Helge JW; Holst JJ; Dela F
J Physiol; 2015 Jul; 593(14):3123-33. PubMed ID: 25867961
[TBL] [Abstract][Full Text] [Related]
10. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
[TBL] [Abstract][Full Text] [Related]
11. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.
Nosso G; Griffo E; Cotugno M; Saldalamacchia G; Lupoli R; Pacini G; Riccardi G; Angrisani L; Capaldo B
Horm Metab Res; 2016 May; 48(5):312-7. PubMed ID: 26788926
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.
Purnell JQ; Johnson GS; Wahed AS; Dalla Man C; Piccinini F; Cobelli C; Prigeon RL; Goodpaster BH; Kelley DE; Staten MA; Foster-Schubert KE; Cummings DE; Flum DR; Courcoulas AP; Havel PJ; Wolfe BM
Diabetologia; 2018 May; 61(5):1142-1154. PubMed ID: 29428999
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
18. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
[TBL] [Abstract][Full Text] [Related]
19. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
20. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
